Sanford Burnham Prebys announces start of Phase 2 clinical trial of DS-1211 in individuals with PseudoXanthoma Elasticum

Daiichi Sankyo initiates Phase 2 trial for drug developed with Sanford Burnham Prebys
Click here to view original post